|
NOVARTIS LAUNCHES LARGEST DIABETES PREVENTION TRIAL TO …
Free with registration - PR Newswire - AccessMyLibrary.com - Sep 8, 2001
... (valsartan) reduce or delay the development of type 2 diabetes and cardiovascular ... Diovan is an angiotensin II receptor blocker (ARB) indicated for ...
|
|
|
NOVARTIS LAUNCHES LARGEST DIABETES PREVENTION TRIAL TO …
Free with registration - AsiaPulse News - AccessMyLibrary.com - Sep 10, 2001
... of Starlix(R) (nateglinide) or Diovan(R) (valsartan) reduce or delay the ... Participants will be aged at least 50 with at least one cardiovascular ...
|
|
Largest Prevention Trial To Date Launched.
Free with registration - Drug Week - AccessMyLibrary.com - Oct 12, 2001
... administration of Starlix (nateglinide) or Diovan (valsartan) reduce or ... This phase will last until 1000 subjects have had a cardiovascular event. ...
|
|
Largest Prevention Trial To Date Launched.(Brief Article)
Free with registration - Diabetes Week - AccessMyLibrary.com - Oct 8, 2001
... administration of Starlix (nateglinide) or Diovan (valsartan) reduce or ... This phase will last until 1000 subjects have had a cardiovascular event. ...
|
|
NOVARTIS TO RECRUIT FIRST PATIENTS INTO NAVIGATOR - …
Free with registration - PR Newswire - AccessMyLibrary.com - Nov 12, 2001
... of Starlix(r) (nateglinide) or Diovan(r) (valsartan) reduce or delay the ... Alarmingly, cardiovascular complications like Mr Shah's may well have begun ...
|
|
|
… TRIAL, DESIGNED TO DETERMINE THE EFFECT OF DIOVAN ON LO
Free with registration - PR Newswire - AccessMyLibrary.com - Jun 27, 2001
"We are proud to be working with the world's leading cardiovascular centres on ... 2,3) The ARB Diovan provides a more complete blockade of the RAS than ACE ...
|
|
Novartis Pharma Schweiz AG
presseportal.ch - Jun 4, 2001
After arterial injury due to stenting, Diovan, by selectively blocking the AT1 receptor, may reduce vascular smooth muscle cell migration and proliferation ...
|
|
